| Enriched cancer pathway | Genes under regulation | P value |
|---|
| Wnt signaling pathway |
12 genes: NFAT5, CSNK1A1, PRICKLE2, DAAM1, RHOA, NFATC2, NFATC4, PRKCA, CAMK2A, FZD7, TCF7L1, CCND2
|
2.026e-05 |
| Axon guidance |
9 genes: NFAT5, EPHA7, ABLIM3, RHOA, NFATC2, NFATC4, PLXNA2, SLIT3, UNC5C
|
0.0006084 |
| Long.term potentiation |
6 genes: GRIN2A, ITPR1, PRKCA, RPS6KA2, CAMK4, CAMK2A
|
0.001669 |
| Osteoclast differentiation |
8 genes: SIRPA, CYBB, CYLD, IL1R1, NFATC2, SYK, CAMK4, SOCS3
|
0.00232 |
| Calcium signaling pathway |
9 genes: GRIN2A, ITPR1, PHKB, PLN, PRKCA, BDKRB2, SLC8A1, CAMK4, CAMK2A
|
0.005058 |
| Adipocytokine signaling pathway |
5 genes: ACSL4, LEP, LEPR, PPARA, SOCS3
|
0.007759 |
| Neurotrophin signaling pathway |
7 genes: FOXO3, RHOA, NTRK2, BCL2, RPS6KA2, CAMK4, CAMK2A
|
0.008425 |
| MAPK signaling pathway |
11 genes: MAP3K2, DUSP3, MRAS, IL1R1, MEF2C, NFATC2, NFATC4, NTRK2, PRKCA, RPS6KA2, SRF
|
0.00996 |
| Dorso.ventral axis formation |
3 genes: ETS1, NOTCH2, PIWIL2
|
0.01007 |
| Adherens junction |
5 genes: FER, RHOA, VCL, TCF7L1, IQGAP1
|
0.0104 |
| Lysine degradation |
3 genes: ALDH1B1, ASH1L, SETD7
|
0.04514 |
| B cell receptor signaling pathway |
4 genes: NFAT5, NFATC2, NFATC4, SYK
|
0.04711 |
| VEGF signaling pathway |
4 genes: NFAT5, NFATC2, NFATC4, PRKCA
|
0.04905 |